| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.3 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |